Mehak Arora

Mehak Arora

Auto-generated profile, based on publicly available information

Mehak Arora

All India Institute of Medical Sciences (AIIMS), New Delhi, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
SCSakshi Chopra
Sakshi Chopra
Piyush RanjanPiyush Ranjan
Piyush Ranjan
VSVishwajeet Singh
Vishwajeet Singh
SKSuraj Kumar
Suraj Kumar
MAMehak Arora
Mehak Arora
UBUpendra Baitha
Upendra Baitha

1 May 2021 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
AKArchana Kumari
Archana Kumari
Piyush RanjanPiyush Ranjan
Piyush Ranjan
SCSakshi Chopra
Sakshi Chopra
DKDivjyot Kaur
Divjyot Kaur
AUAshish Datt Upadhyay
Ashish Datt Upadhyay
NVNaval K. Vikram
Naval K. Vikram

1 February 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
MGMohak Gupta
Mohak Gupta
RMRishika Mohanta
Rishika Mohanta
ARAditi Rao
Aditi Rao
GPGiridara Gopal Parameswaran
Giridara Gopal Parameswaran
MAMudit Agarwal
Mudit Agarwal
SBSushma Bhatnagar
Sushma Bhatnagar
• The basic reproduction number R0 for India was 2.08. • The Rt for India reduced to 1.16 on 22 April, about a month into the nation-wide lockdown. • A gradual lockdown relaxation farther after the first peak has passed is beneficial. • Testing and isolation prevent more secondary infections when social restrictions are relaxed. • Ramping up testing has many benefits and is much more economically feasible than extending lockdowns.

30 April 2020 in F1000Research
Verified
Journal Article
Open access
PDF file
AMArchisman Mazumder
Archisman Mazumder
MAMehak Arora
Mehak Arora
VBVishwesh Bharadiya
Vishwesh Bharadiya
PBParul Berry
Parul Berry
MAMudit Agarwal
Mudit Agarwal
GPGiridara Gopal Parameswaran
Giridara Gopal Parameswaran
Background: After SARS-CoV-2 set foot in India, the Government took a number of steps to limit the spread of the virus in the country. This included restricted testing, isolation, contact tracing and quarantine, and enforcement of a nation-wide lockdown starting 25 March 2020. The objectives of this study were to i) describe the age, gender distribution, and mortality among COVID-19 patients identified till 14 April 2020 and predict the range of contact rate; and ii) predict the number of COVID-19 infections after 40 days of lockdown. Methods: We used a cross-sectional descriptive design for the first objective and a susceptible-infected-removed model for in silico predictions. We collected data from government-controlled and crowdsourced websites. Results: Studying age and gender parameters of 1161 Indian COVID-19 patients, the median age was 38 years (IQR, 27-52) with 20-39 year-old males being the most affected group. The number of affected patients were 854 (73.6%) men and 307 (26.4%) women. If the current contact rate continues (0.25-27), India may have 110460 to 220575 infected persons at the end of 40 days lockdown. Conclusion: The disease is majorly affecting a younger age group in India. Interventions have been helpful in preventing the worst-case scenario in India but will be unable to prevent the spike in the number of cases.

27 July 2020 in Epidemiology and Infection
Verified
Journal Article
Open access
PDF file
AMA. Mazumder
A. Mazumder
MAM. Arora
M. Arora
MSM. S. Sra
M. S. Sra
AGA. Gupta
A. Gupta
PBP. Behera
P. Behera
HSHemant Deepak Shewade
Hemant Deepak Shewade
Case fatality rate (CFR) and doubling time are important characteristics of any epidemic. For coronavirus disease 2019 (COVID-19), wide variations in the CFR and doubling time have been noted among various countries. Early in the epidemic, CFR calculations involving all patients as denominator do not account for the hospitalised patients who are ill and will die in the future. Hence, we calculated cumulative CFR (cCFR) using only patients whose final clinical outcomes were known at a certain time point. We also estimated the daily average doubling time. Calculating CFR using this method leads to temporal stability in the fatality rates, the cCFR stabilises at different values for different countries. The possible reasons for this are an improved outcome rate by the end of the epidemic and a wider testing strategy. The United States, France, Turkey and China had high cCFR at the start due to low outcome rate. By 22 April, Germany, China and South Korea had a low cCFR. China and South Korea controlled the epidemic and achieved high doubling times. The doubling time in Russia did not cross 10 days during the study period.

30 April 2020 in F1000Research
Verified
Journal Article
Open access
AMArchisman Mazumder
Archisman Mazumder
MAMehak Arora
Mehak Arora
VBVishwesh Bharadiya
Vishwesh Bharadiya
PBParul Berry
Parul Berry
MAMudit Agarwal
Mudit Agarwal
GPGiridara Gopal Parameswaran
Giridara Gopal Parameswaran
Background: After SARS-CoV-2 set foot in India, the Government took a number of steps to limit the spread of the virus in the country. This included restricted testing, isolation, contact tracing and quarantine, and enforcement of a nation-wide lockdown starting 25 March 2020. The objectives of this study were to i) describe the age,gender distribution and mortality among COVID-19 patients identified till 14 April 2020 and predict the range of contact rate; and ii) predict the number of active COVID-19 patients after 40 days of lockdown. Methods: We used a cross-sectional descriptive design for first objective and a susceptible-infected-removed model for in silico predictions. We collected data from government-controlled and crowdsourced websites. Results: Studying age and gender parameters of 1161 Indian COVID-19 patients, the median age was 38 years (IQR, 27-52) with 20-39 year-old males being the most affected group. The number of affected patients were 854 (73.6%) men and 307 (26.4%) women. If the current contact rate continues (0.25-27), India may have 110460 to 220575 infected persons at the end of 40 days lockdown. Conclusion: The disease is majorly affecting a younger age group in India. Interventions have been helpful in preventing the worst-case scenario in India, but will be unable to prevent the spike in number of cases.